{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T17:13:08Z","timestamp":1772817188914,"version":"3.50.1"},"reference-count":17,"publisher":"Royal College of Psychiatrists","issue":"5","license":[{"start":{"date-parts":[[2018,1,29]],"date-time":"2018-01-29T00:00:00Z","timestamp":1517184000000},"content-version":"unspecified","delay-in-days":12692,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Psychiatry"],"published-print":{"date-parts":[[1983,5]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>The prevalence of an abnormal response to the dexamethasone suppression test (DST) was examined in 119 in-patients suffering from a major depressive disorder and in 79 normal controls. Only 11 per cent of controls showed an abnormal DST as against 70 per cent of depressed patients. The specificity of the DST was examined by testing patients with other psychiatric disorders. Abnormal responses were found in one-fifth of a sample of schizophrenics, over one-quarter of abstinent alcoholics, two-fifths of neurotics (including neurotic depressives) and almost half of senile dements. Abnormal DST was also found in 33 per cent of patients receiving prophylactic lithium for recurrent affective disorders.<\/jats:p>","DOI":"10.1192\/bjp.142.5.498","type":"journal-article","created":{"date-parts":[[2008,8,12]],"date-time":"2008-08-12T23:20:52Z","timestamp":1218583252000},"page":"498-504","source":"Crossref","is-referenced-by-count":226,"title":["Dexamethasone Suppression Test in Depression and other Psychiatric Illness"],"prefix":"10.1192","volume":"142","author":[{"given":"A.","family":"Coppen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Abou-Saleh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Milln","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Metcalfe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Harwood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"170","published-online":{"date-parts":[[2018,1,29]]},"reference":[{"key":"S000712500011579X_ref15","article-title":"Genetic subtypes of unipolar primary depressive illness distinguished by hypothalamic-pituitary-adrenal axis activity","volume":"i","author":"Schlesser","year":"1979","journal-title":"Lancet,"},{"key":"S000712500011579X_ref14","volume-title":"Unpublished PhD Thesis","author":"Salkind","year":"1973"},{"key":"S000712500011579X_ref11","article-title":"NOSIE 30, a treatment-sensitive ward behaviour scale","volume":"19","author":"Honingfeld","year":"1966","journal-title":"Psychological Reports"},{"key":"S000712500011579X_ref10","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.6132.266"},{"key":"S000712500011579X_ref7","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.280.6207.66"},{"key":"S000712500011579X_ref6","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.140.3.292"},{"key":"S000712500011579X_ref5","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1981.01780260017001"},{"key":"S000712500011579X_ref3","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.111.477.659"},{"key":"S000712500011579X_ref13","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291700052934"},{"key":"S000712500011579X_ref4","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.3.5613.285"},{"key":"S000712500011579X_ref8","article-title":"Effect of dexamethasone on plasma cortico-steroids in depressive illness","volume":"1","author":"Gibbons","year":"1966","journal-title":"Neuroendocrinology"},{"key":"S000712500011579X_ref17","volume-title":"Mental Disorders: Glossary and Guide to their Classification in Accordance with the Ninth Revision of the International Classification of Diseases.","year":"1978"},{"key":"S000712500011579X_ref2","article-title":"Pituitary-adrenal function in severe depressive illness","volume":"2","author":"Butler","year":"1968","journal-title":"Lancet,"},{"key":"S000712500011579X_ref16","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1978.01770300115013"},{"key":"S000712500011579X_ref1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1961.01710120031004"},{"key":"S000712500011579X_ref12","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.137.4.324"},{"key":"S000712500011579X_ref9","doi-asserted-by":"publisher","DOI":"10.1111\/j.2044-8260.1967.tb00530.x"}],"container-title":["British Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S000712500011579X","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T19:14:54Z","timestamp":1558725294000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S000712500011579X\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1983,5]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1983,5]]}},"alternative-id":["S000712500011579X"],"URL":"https:\/\/doi.org\/10.1192\/bjp.142.5.498","relation":{},"ISSN":["0007-1250","1472-1465"],"issn-type":[{"value":"0007-1250","type":"print"},{"value":"1472-1465","type":"electronic"}],"subject":[],"published":{"date-parts":[[1983,5]]}}}